Zydus Lifesciences informs about press release

07 Jan 2025 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated January 7, 2025, titled ‘Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM and ZituvimetTM XR (Sitagliptin Sitagliptin and Metformin Hydrochloride) to its template formulary’.

The above information is a part of company’s filings submitted to BSE.



Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×